jelena

COUR NanoParticle (CNP) Technology Induces Antigen Specific Tolerance, Halting the Progression of Type 1 Diabetes in Spontaneous NOD Model

… [Read more...] about COUR NanoParticle (CNP) Technology Induces Antigen Specific Tolerance, Halting the Progression of Type 1 Diabetes in Spontaneous NOD Model

Cour Pharmaceuticals Releases Data on Potential Breakthrough Treatment for Celiac Disease

Proprietary Antigen-specific Nanoparticles and … [Read more...] about Cour Pharmaceuticals Releases Data on Potential Breakthrough Treatment for Celiac Disease